Molecular basis of inhibition of the amino acid transporter B
Journal
Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555
Informations de publication
Date de publication:
22 Aug 2024
22 Aug 2024
Historique:
received:
09
01
2024
accepted:
09
08
2024
medline:
23
8
2024
pubmed:
23
8
2024
entrez:
22
8
2024
Statut:
epublish
Résumé
The epithelial neutral amino acid transporter B
Identifiants
pubmed: 39174516
doi: 10.1038/s41467-024-51748-1
pii: 10.1038/s41467-024-51748-1
doi:
Substances chimiques
Amino Acid Transport Systems, Neutral
0
SLC6A19 protein, human
0
SLC6A19 protein, mouse
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
7224Subventions
Organisme : Department of Health | National Health and Medical Research Council (NHMRC)
ID : GNT2020757
Informations de copyright
© 2024. The Author(s).
Références
Broer, S. & Gauthier-Coles, G. Amino acid homeostasis in mammalian cells with a focus on amino acid transport. J. Nutr. 152, 16–28 (2022).
pubmed: 34718668
doi: 10.1093/jn/nxab342
Blau, N., Duran, M., Gibson, K. M. & Dionisi-Vici, C. Physician’s guide to the diagnosis, treatment, and follow-up of inherited metabolic disease. 3-141 (Springer-Verlag, 2014).
Holecek, M. Why are branched-chain amino acids increased in starvation and diabetes? Nutrients 12, 3087 (2020).
pubmed: 33050579
pmcid: 7600358
doi: 10.3390/nu12103087
White, P. J. et al. Insulin action, type 2 diabetes, and branched-chain amino acids: A two-way street. Mol. Metab. 101261 https://doi.org/10.1016/j.molmet.2021.101261 (2021).
Palacin, M. & Broer, S. in Physician’s Guide to the Diagnosis, Treatment, and Follow-Up of Inherited Metabolic Diseases (eds B. Thöny, M. Duran, K. M. Gibson, & C. Dionisi-Vici) 85-99 (Springer-Verlag, 2014).
Seow, H. F. et al. Hartnup disorder is caused by mutations in the gene encoding the neutral amino acid transporter SLC6A19. Nat. Genet 36, 1003–1007 (2004).
pubmed: 15286788
doi: 10.1038/ng1406
Belanger, A. M. et al. Inhibiting neutral amino acid transport for the treatment of phenylketonuria. JCI Insight 3, e121762 (2018).
pubmed: 30046012
pmcid: 6124451
doi: 10.1172/jci.insight.121762
Belanger, A. J. et al. Excretion of excess nitrogen and increased survival by loss of SLC6A19 in a mouse model of ornithine transcarbamylase deficiency. Journal of Inherited Metabolic Disease n/a https://doi.org/10.1002/jimd.12568 (2022).
Jiang, Y. et al. Mice lacking neutral amino acid transporter B(0)AT1 (Slc6a19) have elevated levels of FGF21 and GLP-1 and improved glycaemic control. Mol. Metab. 4, 406–417 (2015).
pubmed: 25973388
pmcid: 4421019
doi: 10.1016/j.molmet.2015.02.003
Yadav, A. et al. Novel chemical scaffolds to inhibit the neutral amino acid transporter B(0)AT1 (SLC6A19), a potential target to treat metabolic diseases. Front. Pharm. 11, 140 (2020).
doi: 10.3389/fphar.2020.00140
Navarro-Garrido, A. et al. Aristolochic acid-induced nephropathy is attenuated in mice lacking the neutral amino acid transporter B(0)AT1 (Slc6a19). Am. J. Physiol. Renal Physiol. https://doi.org/10.1152/ajprenal.00181.2022 (2022).
Pochini, L. et al. Nimesulide binding site in the B0AT1 (SLC6A19) amino acid transporter. Mechanism of inhibition revealed by proteoliposome transport assay and molecular modelling. Biochem Pharm. 89, 422–430 (2014).
pubmed: 24704252
doi: 10.1016/j.bcp.2014.03.014
Desai, J. et al. Discovery of novel, potent and orally efficacious inhibitor of neutral amino acid transporter B(0)AT1 (SLC6A19). Bioorg. Med Chem. Lett. 53, 128421 (2021).
pubmed: 34718128
doi: 10.1016/j.bmcl.2021.128421
Cheng, Q. et al. Identification of novel inhibitors of the amino acid transporter B(0) AT1 (SLC6A19), a potential target to induce protein restriction and to treat type 2 diabetes. Br. J. Pharm. 174, 468–482 (2017).
doi: 10.1111/bph.13711
Danthi, S. J. et al. Identification and characterization of inhibitors of a neutral amino acid transporter, SLC6A19, using two functional cell-based assays. SLAS Discov. 2472555218794627 https://doi.org/10.1177/2472555218794627 (2018).
Gerbeth-Kreul, C. et al. A solid supported membrane-based technology for electrophysical screening of B(0)AT1-modulating compounds. SLAS Discov. 26, 783–797 (2021).
pubmed: 33955247
doi: 10.1177/24725552211011180
Broer, S. & Gether, U. The solute carrier 6 family of transporters. Br. J. Pharm. 167, 256–278 (2012).
doi: 10.1111/j.1476-5381.2012.01975.x
Danilczyk, U. et al. Essential role for collectrin in renal amino acid transport. Nature 444, 1088–1091 (2006).
pubmed: 17167413
doi: 10.1038/nature05475
Kowalczuk, S. et al. A protein complex in the brush-border membrane explains a Hartnup disorder allele. FASEB J. 22, 2880–2887 (2008).
pubmed: 18424768
doi: 10.1096/fj.08-107300
Yan, R. et al. Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2. Science 367, 1444–1448 (2020).
pubmed: 32132184
pmcid: 7164635
doi: 10.1126/science.abb2762
Shi, L., Quick, M., Zhao, Y., Weinstein, H. & Javitch, J. A. The mechanism of a neurotransmitter:sodium symporter-inward release of Na+ and substrate is triggered by substrate in a second binding site. Mol. Cell 30, 667–677 (2008).
pubmed: 18570870
pmcid: 2826427
doi: 10.1016/j.molcel.2008.05.008
Navratna, V. & Gouaux, E. Insights into the mechanism and pharmacology of neurotransmitter sodium symporters. Curr. Opin. Struct. Biol. 54, 161–170 (2019).
pubmed: 30921707
pmcid: 6592764
doi: 10.1016/j.sbi.2019.03.011
Cheng, M. H. & Bahar, I. Monoamine transporters: structure, intrinsic dynamics and allosteric regulation. Nat. Struct. Mol. Biol. 26, 545–556 (2019).
pubmed: 31270469
pmcid: 6712983
doi: 10.1038/s41594-019-0253-7
Niello, M., Gradisch, R., Loland, C. J., Stockner, T. & Sitte, H. H. Allosteric modulation of neurotransmitter transporters as a therapeutic strategy. Trends Pharm. Sci. 41, 446–463 (2020).
pubmed: 32471654
doi: 10.1016/j.tips.2020.04.006
Shotwell, M. A., Jayme, D. W., Kilberg, M. S. & Oxender, D. L. Neutral amino acid transport systems in Chinese hamster ovary cells. J. Biol. Chem. 256, 5422–5427 (1981).
pubmed: 7240147
doi: 10.1016/S0021-9258(19)69218-5
Broer, S. & Broer, A. Amino acid homeostasis and signalling in mammalian cells and organisms. Biochem J. 474, 1935–1963 (2017).
pubmed: 28546457
doi: 10.1042/BCJ20160822
Fairweather, S. J. et al. A GC-MS/single-cell method to evaluate membrane transporter substrate specificity and signaling. Front Mol. Biosci. 8, 646574 (2021).
pubmed: 33928121
pmcid: 8076599
doi: 10.3389/fmolb.2021.646574
Gauthier-Coles, G. et al. Quantitative modelling of amino acid transport and homeostasis in mammalian cells. Nat. Commun. 12, 5282 (2021).
pubmed: 34489418
pmcid: 8421413
doi: 10.1038/s41467-021-25563-x
Wempe, M. F. et al. Metabolism and pharmacokinetic studies of JPH203, an L-amino acid transporter 1 (LAT1) selective compound. Drug Metab. Pharmacokinet. 27, 155–161 (2012).
pubmed: 21914964
doi: 10.2133/dmpk.DMPK-11-RG-091
Esslinger, C. S., Cybulski, K. A. & Rhoderick, J. F. Ngamma-aryl glutamine analogues as probes of the ASCT2 neutral amino acid transporter binding site. Bioorg. Med Chem. 13, 1111–1118 (2005).
pubmed: 15670919
doi: 10.1016/j.bmc.2004.11.028
Kuhn, B., Mohr, P. & Stahl, M. Intramolecular hydrogen bonding in medicinal chemistry. J. Med Chem. 53, 2601–2611 (2010).
pubmed: 20175530
doi: 10.1021/jm100087s
Cavallo, G. et al. The Halogen Bond. Chem. Rev. 116, 2478–2601 (2016).
pubmed: 26812185
pmcid: 4768247
doi: 10.1021/acs.chemrev.5b00484
Cinčić, D., Friščić, T. & Jones, W. Isostructural materials achieved by using structurally equivalent donors and acceptors in halogen-bonded cocrystals. Chem. – A Eur. J. 14, 747–753 (2008).
doi: 10.1002/chem.200701184
Shen, Y. et al. Structures of ACE2-SIT1 recognized by Omicron variants of SARS-CoV-2. Cell Discov. 8, 123 (2022).
pubmed: 36384914
pmcid: 9667838
doi: 10.1038/s41421-022-00488-x
Wobst, H. et al. A small molecule slc6a19 inhibitor increases urinary phenylalanine excretion and reduces its pathogenic plasma accumulation in a phenylketonuria mouse model. Mol. Genet. Metab. 138, 107502 (2023).
doi: 10.1016/j.ymgme.2023.107502
Silbernagl, S. Cycloleucine (1-amino-cyclopentane carboxylic acid): tubular reabsorption and inhibitory effect on amino acid transport in the rat kidney. (Microperfusion experiments). Pflug. Arch. 353, 241–253 (1975).
doi: 10.1007/BF00584287
Wilensky, A. J., Lane, E. A., Levy, R. H., Ojemann, L. M. & Friel, P. N. Differential kinetics of cinromide and two of its metabolites in epileptic patients. Eur. J. Clin. Pharm. 21, 149–153 (1981).
doi: 10.1007/BF00637516
Coleman, J. A. & Gouaux, E. Structural basis for recognition of diverse antidepressants by the human serotonin transporter. Nat. Struct. Mol. Biol. 25, 170–175 (2018).
pubmed: 29379174
pmcid: 5962350
doi: 10.1038/s41594-018-0026-8
Plenge, P. et al. The mechanism of a high-affinity allosteric inhibitor of the serotonin transporter. Nat. Commun. 11, 1491 (2020).
pubmed: 32198394
pmcid: 7083837
doi: 10.1038/s41467-020-15292-y
Quick, M. et al. The LeuT-fold neurotransmitter:sodium symporter MhsT has two substrate sites. Proc. Natl Acad. Sci. USA 115, E7924–E7931 (2018).
pubmed: 30082383
pmcid: 6112694
doi: 10.1073/pnas.1717444115
Li, Y. et al. Structural insight into the substrate recognition and transport mechanism of amino acid transporter complex ACE2-B(0)AT1 and ACE2-SIT1. Cell Discov. 9, 93 (2023).
pubmed: 37684251
pmcid: 10491607
doi: 10.1038/s41421-023-00596-2
Zhang, K. Gctf: Real-time CTF determination and correction. J. Struct. Biol. 193, 1–12 (2016).
pubmed: 26592709
pmcid: 4711343
doi: 10.1016/j.jsb.2015.11.003
Zivanov, J. et al. New tools for automated high-resolution cryo-EM structure determination in RELION-3. Elife 7, e42166 (2018).
pubmed: 30412051
pmcid: 6250425
doi: 10.7554/eLife.42166
Kimanius, D., Forsberg, B. O., Scheres, S. H. & Lindahl, E. Accelerated cryo-EM structure determination with parallelisation using GPUs in RELION-2. Elife 5, e18722 (2016).
pubmed: 27845625
pmcid: 5310839
doi: 10.7554/eLife.18722
Scheres, S. H. RELION: implementation of a Bayesian approach to cryo-EM structure determination. J. Struct. Biol. 180, 519–530 (2012).
pubmed: 23000701
pmcid: 3690530
doi: 10.1016/j.jsb.2012.09.006
Scheres, S. H. A Bayesian view on cryo-EM structure determination. J. Mol. Biol. 415, 406–418 (2012).
pubmed: 22100448
pmcid: 3314964
doi: 10.1016/j.jmb.2011.11.010
Punjani, A., Rubinstein, J. L., Fleet, D. J. & Brubaker, M. A. cryoSPARC: algorithms for rapid unsupervised cryo-EM structure determination. Nat. Methods 14, 290–296 (2017).
pubmed: 28165473
doi: 10.1038/nmeth.4169
Rosenthal, P. B. & Henderson, R. Optimal determination of particle orientation, absolute hand, and contrast loss in single-particle electron cryomicroscopy. J. Mol. Biol. 333, 721–745 (2003).
pubmed: 14568533
doi: 10.1016/j.jmb.2003.07.013
Emsley, P., Lohkamp, B., Scott, W. G. & Cowtan, K. Features and development of Coot. Acta Crystallogr. Sect. D., Biol. Crystallogr. 66, 486–501 (2010).
doi: 10.1107/S0907444910007493
Adams, P. D. et al. PHENIX: a comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr. Sect. D., Biol. Crystallogr. 66, 213–221 (2010).
doi: 10.1107/S0907444909052925